PATENT CLAIM ANALYSIS

Application Number: 16163076
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "484000"]

Abstract:
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.

Claim (Index 56):
The method of  claim 53 , wherein the wax comprises carnauba wax.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.50704
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15015722', '15019304', '15015763', '15015769', '15013628']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7919151957257392
- 35 USC 102 Novelty (BERT): 0.5649908516446902
- Combined Prediction Score: 0.7692227613176343
- Mean Citation Score: 492.13263600000016
- Max Citation Score: 546.9646
- Similarity Product: 318.903478703475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test